Article info

Download PDFPDF
Analysis of FDA’s Vuse market authorisation: limitations and opportunities

Authors

  1. Correspondence to Dr Andrew B Meshnick, Pediatrics, University of Vermont Children's Hospital, Burlington, VT 05401, USA; abm75{at}georgetown.edu
View Full Text

Citation

Meshnick AB, Faricy LE, Lushniak BD
Analysis of FDA’s Vuse market authorisation: limitations and opportunities

Publication history

  • Received May 20, 2022
  • Accepted November 4, 2022
  • First published February 9, 2023.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.